A legal analysis published in Ars Aequi last week situates the General Court’s judgment in Stevi and the New York Times Company v Commission (commonly referred to as the ‘Pfizergate’ case) within the broader context of ‘alternative documents’ regimes in the Commission and Council of the EU. In this blog post, first author Andra Primavarus sets out the core argument.
